Medicine & Life Sciences
Prostatic Neoplasms
100%
Castration
70%
Neoplasms
59%
MDV 3100
56%
Androgens
40%
Survival
39%
abiraterone
38%
Squamous Cell Carcinoma of Head and Neck
38%
Colorectal Neoplasms
32%
Adenocarcinoma
31%
Prostate-Specific Antigen
31%
Therapeutics
29%
Progression-Free Survival
26%
Nivolumab
23%
Mutation
23%
Turcot syndrome
22%
Head and Neck Neoplasms
22%
Radiotherapy
21%
Biomarkers
20%
Androgen Receptors
18%
Bacteroides fragilis
18%
DNA Mismatch Repair
17%
Immunotherapy
16%
T-Lymphocytes
15%
Fluorodeoxyglucose F18
15%
Prostatectomy
15%
Tumor Burden
14%
Melanoma
14%
Neoplasm Metastasis
13%
Colon
12%
Circulating Neoplastic Cells
12%
Confidence Intervals
12%
Radiosurgery
11%
Clinical Trials
11%
Tumor-Infiltrating Lymphocytes
10%
DNA Repair
10%
Radium-223
10%
Pancreatic Neoplasms
10%
Genes
10%
Relative Biological Effectiveness
9%
Drug Therapy
9%
Ipilimumab
9%
Antibodies
8%
Vaccination
8%
Carcinoma
8%
Mesenchymal Stem Cells
8%
Immunity
8%
Tumor Microenvironment
8%
Poly(ADP-ribose) Polymerase Inhibitors
8%
Meta-Analysis
8%